The U.S. Food and Drug Administration (FDA) issued a Safety Communication today reminding consumers and health care providers that currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19.
SARS-CoV-2 antibody tests help identify whether someone has antibodies to SARS-CoV-2, the beta coronavirus that causes COVID-19, indicating a prior virus infection.
The FDA stated on May 19, 2021, these antibody test results can be misinterpreted, especially after the person received a COVID-19 vaccination.
mRNA COVID-19 Vaccine Antibody Test Results Require Professional Interpretation
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?
Since the beginning of the COVID-19 pandemic, reduced incidence of many viral and bacterial infections has been reported in children: bronchiolitis, varicella, measles, pertussis, pneumococcal and meningococcal invasive diseases. The […]
Multisystemic inflammatory syndrome in a young adult after SARS-CoV2 infection: case report.
SARS-CoV-2 infection may precede the appearance of dysregulated immune responses adopting form of multisystemic inflammatory syndrome in adults (MIS-A), that can be fatal because of end-organ damage. We present a […]
Limits of remote working: the ethical challenges in conducting Mental Health Act assessments during COVID-19.
COVID-19 has created additional challenges in mental health services, including the impact of social distancing measures on care and treatment. For situations where a detention under mental health legislation is […]
Converting to a Synchronous Virtual Nursing Research Conference Amidst a Pandemic: A Case Study.
University of California San Diego Health was set to launch its 13th annual Nursing and Inquiry Innovation Conference event in June 2020. However, the Coronavirus Disease 2019 (COVID-19) pandemic placed […]
Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany.
The aim of this study was to investigate the frequency of newly diagnosed type 1 diabetes without evidence of autoimmunity and the respective frequencies of ketoacidosis in children, adolescents, and […]
The perception of training and professional development according to nursing students as health workers during COVID-19: A qualitative study.
To explore the perception of education and professional development of final-year nursing students who carried out health relief tasks during the COVID-19 pandemic.The COVID-19 pandemic has led to a global […]
Don't Hesitate, Early Monoclonal Treatment Advised for Certain COVID-19 Patients
A COVID-19 treatment that is given early after coronavirus infection cuts the risk of hospitalization and death by 60% in those patients most likely to suffer complications of the disease, according to an analysis of 232 University of Pittsburgh Medical Center (UPMC) patients.
Hospitalization Rates Overestimate COVID-19 Burden in Children
Almost 40 percent of the SARS-CoV-2-positive pediatric patients with hospitalization were asymptomatic
Less Than 1 Percent of COVID-19 Patients Experience Recurrence
90 percent of repeat positive tests ≥60 days from initial diagnosis are not consistent with true recurrence
- Page 1 of 2
- 1
- 2